Credit Suisse has initiated coverage with an Outperform rating and a Target Price of $124. Their FY21 underlying EBITDA forecast is $159m (vs $44m in FY20), which is the highest I have seen from the relatively large cohort of brokers covering the stock.
The UBS price target has been held at $30 (upgraded from $28.25 on 3 November).